Ying Qi

Ying Qi

Auto-generated profile, based on publicly available information

Ying Qi

Zhejiang Univ, Sch Med, Shaoxing Hosp, Shaoxing Peoples Hosp,Dept Geriatr, Shaoxing City, Zhejiang, Peoples R China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YQYing Qi
Ying Qi
LZLingling Zhao
Lingling Zhao
HSHao Sun
Hao Sun
To examine the composition of lanostanoids in Ganoderma lucidum, we have developed a liquid chromatography–mass spectrometry (LC–MS) method by using the ganoderic acids isolated in our laboratory as reference standards. The identity of 14 peaks in the high performance liquid chromatogram (HPLC) of G. lucidum has been confirmed. By using the HPLC retention times of these ganoderic acids and their mass fragmentation patterns established in this paper, one can use LC–MS to analyze G. lucidum without requiring the reference standards of these 14 ganoderic acids. Subsequently, only the HPLC–UV method would be needed to analyze routine samples of G. lucidum.

1 September 2022 in The Anatolian Journal of Cardiology
Verified
Journal Article
Open access
ZYZhangjie Yu
Zhangjie Yu
YXYangbo Xing
Yangbo Xing
JPJiahao Peng
Jiahao Peng
BXBuyun Xu
Buyun Xu
YQYing Qi
Ying Qi
FPFang Peng
Fang Peng
Atrial fibrillation; heart failure; catheter ablation

30 January 2025 in Boletin Latinoamericano Y Del Caribe de Plantas Medicinales Y Aromaticas
Verified
Journal Article
Closed access
SHShaoxing People'S Hospital
Shaoxing People'S Hospital
ZYZhangjie Yu
Zhangjie Yu
FPFang Peng
Fang Peng
HLHanxuan Liu
Hanxuan Liu
YQYinyin Qiu
Yinyin Qiu
WTWeiliang Tang
Weiliang Tang
This study investigates the efficacy and mechanisms of Kuanxiong Aerosol (KXA) on coronary microvascular dysfunction (CMD) in rats. Thirty-two Sprague-Dawley rats were divided into control, model, KXA, and nicorandil groups, receiving respective treatments for three weeks. The CMD model was established byinjecting lauric acid into the left ventricle. Compared to the model group, the KXA group showed significant reductions in serum CK-MB, LDH, cTnI, ET-1, TNF-α, IL-6, MDA, and ROS (p<0.01) and increased NO and SOD levels (p<0.01). KXA mitigated apoptosis and ameliorated CMD-associated pathological alterations. Pretreatment with KXA improves endothelial function and microvascular structure by counteracting inflammation, oxidative stress, and apoptosis, thereby improving CMD.